Pacs Group, Stock Current Valuation
| PACS Stock | 13.82 0.01 0.07% |
Valuation analysis of PACS Group, helps investors to measure PACS Group,'s intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that PACS Group,'s price fluctuation is slightly risky at this time. Calculation of the real value of PACS Group, is based on 3 months time horizon. Increasing PACS Group,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PACS stock is determined by what a typical buyer is willing to pay for full or partial control of PACS Group,. Since PACS Group, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PACS Stock. However, PACS Group,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13.82 | Real 13.27 | Hype 13.82 |
The intrinsic value of PACS Group,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence PACS Group,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of PACS Group, helps investors to forecast how PACS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PACS Group, more accurately as focusing exclusively on PACS Group,'s fundamentals will not take into account other important factors: PACS Group, Company Current Valuation Analysis
PACS Group,'s Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current PACS Group, Current Valuation | 8.92 B |
Most of PACS Group,'s fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PACS Group, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, PACS Group, has a Current Valuation of 8.92 B. This is 37.91% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 46.35% higher than that of the company.
PACS Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PACS Group,'s direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PACS Group, could also be used in its relative valuation, which is a method of valuing PACS Group, by comparing valuation metrics of similar companies.PACS Group, is currently under evaluation in current valuation category among its peers.
PACS Fundamentals
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.0007 % | ||||
| Current Valuation | 8.92 B | ||||
| Shares Outstanding | 155.18 M | ||||
| Shares Owned By Insiders | 82.76 % | ||||
| Shares Owned By Institutions | 21.54 % | ||||
| Number Of Shares Shorted | 2.25 M | ||||
| Price To Book | 11.04 X | ||||
| Price To Sales | 1.78 X | ||||
| Revenue | 3.11 B | ||||
| EBITDA | 232.87 M | ||||
| Net Income | 112.87 M | ||||
| Total Debt | 2.85 B | ||||
| Book Value Per Share | 3.75 X | ||||
| Cash Flow From Operations | 63.7 M | ||||
| Short Ratio | 7.61 X | ||||
| Earnings Per Share | 0.61 X | ||||
| Price To Earnings To Growth | 1.43 X | ||||
| Target Price | 41.0 | ||||
| Number Of Employees | 32.43 K | ||||
| Market Capitalization | 6.32 B | ||||
| Total Asset | 3.51 B | ||||
| Retained Earnings | 96.12 M | ||||
| Working Capital | 265.22 M | ||||
| Net Asset | 3.51 B |
About PACS Group, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PACS Group,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PACS Group, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PACS Group, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PACS Stock Analysis
When running PACS Group,'s price analysis, check to measure PACS Group,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PACS Group, is operating at the current time. Most of PACS Group,'s value examination focuses on studying past and present price action to predict the probability of PACS Group,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PACS Group,'s price. Additionally, you may evaluate how the addition of PACS Group, to your portfolios can decrease your overall portfolio volatility.